🇺🇸 FDA
Patent

US 8519158

Androgen receptor modulator compounds and methods

granted A61PA61P1/14A61P15/08

Quick answer

US patent 8519158 (Androgen receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61P, A61P1/14, A61P15/08, A61P15/10, A61P15/16